Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes

被引：2
|
作者：
Chatterjee, Saurav [1 ,2 ]
Chatterjee, Sanjay [3 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Providence VAMC, Providence, RI USA
[3] Apollo Gleneagles Hosp, Kolkata, W Bengal, India
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 158卷 / 08期
关键词：
METAANALYSIS;
D O I：
10.7326/0003-4819-158-8-201304160-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [42] Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review
    Ruan, Zhen
    Zou, Huimin
    Lei, Qing
    Ung, Carolina Oi Lam
    Shi, Honghao
    Hu, Hao
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 555 - 574
  • [43] Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
    Lin, Yi-Hsin
    Huang, Hsuan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 2725 - 2733
  • [44] Type 2 Diabetes Treatment Recommendations Update: Appropriate Use of Dipeptidyl Peptidase-4 Inhibitors
    Cornell, Susan
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (08)
  • [45] Dipeptidyl peptidase-4 inhibitors and cardiovascular events: a protective effect?
    Lamanna, C.
    Monami, M.
    Bartoli, N.
    Zannoni, S.
    Mannucci, E.
    DIABETOLOGIA, 2011, 54 : S109 - S109
  • [46] Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas
    Deacon, C. F.
    Lebovitz, H. E.
    DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 333 - 347
  • [47] Dipeptidyl peptidase-4 inhibitors in type 2 diabetic elderly patient
    Doucet, Jean
    Bauduceau, Bernard
    Blickle, Jean-Frederic
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2011, 9 (02): : 157 - 162
  • [48] Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
    Mega, Cristina
    Teixeira-Lemos, Edite
    Fernandes, Rosa
    Reis, Flavio
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [49] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Wei, Xin
    Bai, Yu
    Wang, Zhuo
    Zheng, Xiaohong
    Jin, Zening
    Liu, Xin
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [50] Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
    Ametov, A. S.
    Gusenbekova, D. G.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 85 - 89
12345